Clinical Trial Update: Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) [Phase 1]

View source ↗

Summary

Phase 1 trial results assessing the safety and initial efficacy signals of Hoodia Gordonii for treatment of nonalcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Hoodia Gordonii

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Non-Alcoholic Fatty Liver Disease | Phase 1 | Status: COMPLETED